Document is current

Article History

First Online: 23 July 2015

Compliance with Ethical Standards

:

: This work was supported by National Institutes of Health grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD060543, to John N. van den Anker) and the National Center for Advancing Translational Sciences (UL1TR000075, to the Children’s National Health System), and by a contract for analytical laboratory services from McNeil Consumer Healthcare (Division of McNEIL-PPC, Inc., Fort Washington, PA, USA, to Diana G. Wilkins). Karel Allegaert was supported by a Fundamental Clinical Investigatorship (1800214N) from the Fund for Scientific Research—Flanders (FWO-Vlaanderen, Belgium). Sarah F. Cook received stipend support from the Howard Hughes Medical Institute (Med into Grad Initiative); Sarah F. Cook and Chris Stockmann were supported by pre-doctoral fellowships from the American Foundation for Pharmaceutical Education; and Jessica K. Roberts was supported by a Pharmacotherapy Subspecialty Award from the Primary Children’s Hospital Foundation (Salt Lake City, UT, USA).

: Sarah Cook, Jessica Roberts, Samira Samiee-Zafarghandy, Chris Stockmann, Amber King, Nina Deutsch, Elaine Williams, Karel Allegaert, Diana Wilkins, Catherine Sherwin, and John van den Anker have no potential conflicts of interest to declare.

: All human studies were approved by the appropriate Ethics Committees and were carried out in concordance with ICH Guidelines for Good Clinical Practice []. Informed consent was obtained prior to study inclusion.